• Home
  • About
  • Webcasts
  • ‘Enforcement 40’ for 2020
  • Enforcement Hall of Fame
  • Contact
Securities Docket
Ankura 480x60
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2013 / February / 27 / Securities-Fraud Suits Backed by Supreme Court in Amgen Case

Securities-Fraud Suits Backed by Supreme Court in Amgen Case

By Securities Docket on February 27, 2013, 11:01 am

The U.S. Supreme Court made it easier for shareholders to press class action securities-fraud suits, ruling that Amgen Inc. must defend against claims that it misled investors about the safety of two drugs for anemia.

The justices, voting 6-3, today said investors can sue as a group without having to first show that misinformation propped up a company’s stock price.

via Securities-Fraud Suits Backed by Supreme Court in Amgen Case – Bloomberg

Blog Widget by LinkWithin

Posted in Class Actions, Top | Tagged Appellate

« Previous Next »

‘Enforcement 40’ for 2020

Securities-Docket_Medium-Rectangle_CaseStudyArrow

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2021 Securities Docket.

Powered by WordPress and Hybrid.